Bloomington, INNCT05137262Now EnrollingIRB Ready

Bladder Cancer Clinical Trial in Bloomington, IN

Access cutting-edge bladder cancer treatment through this clinical trial at a research site in Bloomington. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Bloomington location

Preparing your pre-screening questions...

Expert Care in Bloomington

Access bladder cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related bladder cancer treatment provided free

Apply for This Bloomington Location

Check if you qualify for this bladder cancer clinical trial in Bloomington, IN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bloomington

    Convenient for IN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bloomington site if eligible
  4. 4Begin participation

About This Bladder Cancer Study in Bloomington

This is a phase II randomized study of standard of care (SOC) neo-adjuvant cisplatin chemotherapy (NAC) versus NAC plus durvalumab in patients with either clinical or pathologic intra-pelvic node-positive urothelial carcinoma of the bladder. Patients with cTanyN1-3M0 via American Joint Committee on Cancer (AJCC) 8th edition staging30 will be considered tor enrollment in this trial. We plan to enroll 60 patients. Patients will be randomized 2:1 to the intervention arm with durvalumab plus NAC vs

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Patients must have histological diagnosis of urothelial carcinoma of the bladder and must meet criteria for stage cTanyN1-3M0 disease via AJCC 8th edition staging criteria30
Patients must provide tissue by agreeing to transurethethral biopsy of the bladder and the lymph node prior to initiating treatment. If patient is unable or unwilling to undergo biopsy at screening and tissue is available, patient may be eligibile per PI discretion.
Patients must be ≥18 years of age.
Patients must have pelvic lymph node amenable for biopsy as assessed by treating MD and interventional radiologist.
Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1.
Patients must have a life expectancy of at least 12 weeks.
Patients must have body weight \>30 kg.
Left ventricular ejection fraction ≥ 50%.
Adequate organ function as defined below:
Hematological i. Absolute neutrophil count (ANC) ≥ 1,500/mcL. ii. Platelets ≥100,000 / mcL. iii. Hemoglobin

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bloomington?

Yes, this clinical trial (NCT05137262) has an active research site in Bloomington, IN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Bladder Cancer Treatment Options in Bloomington, IN

If you're searching for bladder cancer treatment options in Bloomington, IN, this clinical trial (NCT05137262) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bloomington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced bladder cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all bladder cancer clinical trials near you to find additional studies recruiting in your area.

More Bladder Cancer Trials in Bloomington, IN

See all bladder cancer clinical trials recruiting in Bloomington — not just this study.

Browse Bladder Cancer Trials in Bloomington

Ready to Join in Bloomington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bloomington, IN